Evidence map›Paper›PMID 41145620›Full record

ArticleScientific reports2025

Upscaling effects on infectious disease emergence risk emphasize the need for local planning in primary prevention within biodiversity hotspots.

Renata L Muylaert, David A Wilkinson, Evita Izza Dwiyanti, David T S Hayman

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Renata L MuylaertSydney School of Veterinary Science, Faculty of Science, The University of Sydney, Sydney, NSW, 2050, Australia. renata.muylaert@sydney.edu.au.
David A WilkinsonUMR ASTRE, CIRAD, INRAE, Université de Montpellier, Plateforme Technologique CYROI, Sainte-Clotilde, Reunion, France.
Evita Izza DwiyantiAlam Sehat Lestari, Jakarta, Indonesia.
David T S HaymanMolecular Epidemiology and Public Health Laboratory, Hopkirk Research Institute, Massey University, Palmerston North, New Zealand.

Funding

Australian Research Council Australian Laureate Fellowship funded by the Australian Government. FL240100037)Royal Society Te Apārangi MAU1701
6 · The paper itself

Abstract

Zoonotic risk assessments are increasingly vital in the wake of recent epidemics. The microbial diversity of parasitic organisms correlates with host species richness, with regions of high biodiversity facing elevated risks of emerging zoonotic infections. While habitat loss and fragmentation reduce species diversity, anthropogenic encroachment, particularly in forested areas, amplifies human exposure to novel pathogens. This study integrates host habitat, biodiversity, human encroachment, and population at risk to estimate novel disease emergence and epidemic risk at multiple spatial scales. Using Java, Indonesia, as a case study, we demonstrate that degrading spatial resolution leads to information loss, with optimal resolutions typically below 2000 m, ideally around 500 m when native-resolution processing is unfeasible. Gravity models of epidemic spread highlight Jakarta and West Java as high-risk areas, with varying contributions from surrounding regions. Our spatial analysis underscores the influence of population centers on forest management and agroforestry practices. These findings offer valuable insights for guiding pandemic prevention research and improving pathogen- and driver-based risk monitoring strategies.

Indexed as

BiodiversityCommunicable Diseases, EmergingPrimary PreventionZoonosesAnimalsEcosystemHumansIndonesiaRisk AssessmentBiodiversityConservationEmerging infectious diseasesForest managementOne healthRemote sensingRisk assessmentSpatial scale

Identifiers

PMID41145620
PMCPMC12559317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.